VALBIOTIS Integrates The EnterNext© PEA-PME 150 Index From Euronext Paris
05 Ottobre 2020 - 7:35AM
Business Wire
Regulatory News:
VALBIOTIS (Paris:ALVAL) (Euronext: ALVAL), a Research &
Development company committed to scientific innovation for
preventing and combating metabolic diseases, announces that it has
joined the EnterNext© PEA-PME 150 index as of the October 1st, 2020
trading session.
The EnterNext© PEA-PME 150 is a stock market index
representative of French equities eligible for PEA-PME. Larger than
the CAC PME, EnterNext© PEA-PME 150 is made up of 150 small and
medium-sized stocks that are among the most liquid.
Jocelyn PINEAU, Chief Finance Officer, member of the management
Board of VALBIOTIS stated: “We are proud to be part of the
EnterNext© index PEA-PME 150 which values the most liquid French
midcap stocks. This achievement thus rewards the growing interest
of investors in our value, whether professional or private. Less
than four years after our IPO, this is a real satisfaction and an
encouragement to continue our constant efforts to communicate to
the market on the progress of our business plan and the execution
of our strategy.“
ABOUT VALBIOTIS VALBIOTIS is a Research & Development
company committed to scientific innovation for preventing and
combating metabolic diseases in response to unmet medical needs.
VALBIOTIS has adopted an innovative approach, aiming to
revolutionize healthcare by developing a new class of nutritional
health solutions designed to reduce the risk of major metabolic
diseases, based on a multi-target approach and made possible by the
use of plant-based ingredients. Its products are intended to be
licensed to players in the health world. VALBIOTIS was founded in
La Rochelle in early 2014 and has formed numerous partnerships with
top academic centers. The Company has established three sites in
France – Périgny, La Rochelle (17) and Riom (63). VALBIOTIS is a
member of the “BPI Excellence” network and received “Innovative
Company“ status awarded by BPI France. Valbiotis has also been
awarded “Young Innovative Company” status and has received major
financial support from the European Union for its research programs
via the European Regional Development Fund (ERDF). VALBIOTIS is a
PEA-SME eligible company. Find out more about VALBIOTIS:
www.valbiotis.com
Name: VALBIOTIS ISIN code: FR0013254851
Mnemonic code: ALVAL EnterNext © PEA-PME 150
DISCLAIMER This press release contains forward-looking
statements about VALBIOTIS’ objectives, based on rational
hypotheses and the information available to the company at the
present time. However, in no way does this constitute a guarantee
of future performance, and these projections may be affected by
changes in economic conditions and financial markets, as well as a
certain number of risks and uncertainties, including those
described in the VALBIOTIS registration document, filed with the
French Financial Markets Regulator (AMF) on 31 July 2020
(application number R 120--018). This document is available on the
Company’s website (www.valbiotis.com). This press release, as well
as the information contained herein, does not constitute an offer
to sell or subscribe to, or a solicitation to purchase or subscribe
to, VALBIOTIS’ shares or securities in any country.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201004005021/en/
VALBIOTIS / CORPORATE COMMUNICATION Carole ROCHER / Marc
DELAUNAY +33 5 46 28 62 58 media@valbiotis.com
ACTIFIN / FINANCIAL COMMUNICATION Stéphane RUIZ +33 1 56 88 11
14 sruiz@actifin.fr
Grafico Azioni Valbiotis (EU:ALVAL)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Valbiotis (EU:ALVAL)
Storico
Da Apr 2023 a Apr 2024